HSTM Stock Analysis: Buy, Sell, or Hold?
HSTM - HealthStream Inc
$22.79
-0.10 (-0.44%)
▼
5d:
-3.19%
30d:
+8.32%
90d:
+14.64%
BUY
HIGH Confidence
Analysis Updated: May 14, 2026 12:00 AM ET
Earnings: May 04, 2026
0d
Get Alerted When HSTM Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: HSTM shows strong fundamentals and good volume confirmation. Solid entry point despite slightly high pricing.
✅ BUY SIGNAL: HSTM shows strong fundamentals and good volume confirmation. Solid entry point despite slightly high pricing.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$30.83
Based on 7.5% avg growth
INTRINSIC VALUE TODAY
$19.14
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: HSTM is currently trading at $22.79, which is considered slightly high relative to its 30-day fair value range of $20.38 to $22.83. The stock's valuation (Forward PE: 26.5) is in line with its historical norms (25.9). At these levels, the market is pricing in 0.7% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, HSTM is in a downtrend. Immediate support is located at $20.34, while resistance sits at $24.40.
Market Sentiment: HSTM has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $32.00 (+40.4%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, HSTM is in a downtrend. Immediate support is located at $20.34, while resistance sits at $24.40.
Market Sentiment: HSTM has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $32.00 (+40.4%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$20.38 -
$22.83
Company Quality Score
61/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
77.1%
All Signals
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 40.4% below Wall St target ($32.00)
- NEUTRAL: Market pricing in 0.7% annual earnings growth - fairly valued
Trading Range Analysis
30-Day Trading Range
$20.38 -
$22.83
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$20.34
Resistance Level
$24.40
Current Trend
Downtrend
Technical data as of
May 14, 2026
Fundamental Context
Forward P/E (Next Year Est.)
26.50
Wall Street Target
$32.00
(+40.4%)
Revenue Growth (YoY)
10.5%
Earnings Growth (YoY)
42.9%
Profit Margin
6.4%
Valuation Premium vs History
+0.7% premium
PE vs Historical
26.5 vs 25.9
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+0.7%
(market-implied from PE analysis)
1-Year Target
$22.95
(+1%)
2-Year Target
$23.11
(+1%)
3-Year Target
$23.27
(+2%)
3-Yr Target (if PE normalizes)
(PE: 27→26)
PE COMPRESSION
$22.75
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 26.5, Growth: 11.0%)
$31.14
(+37%)
Base:
(SPY PE: 22.0, Growth: 11.0%)
$25.90
(+14%)
Bear:
(PE: 18.7, Growth: 11.0%)
$22.02
(-3%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (34x PE), but valuation improves significantly next year (27x PE) as earnings recover.
Trailing PE: 34.16 | Current EPS (TTM): $0.67
Bull Case
$32.32
(+42%)
Analyst growth 28.4%, PE expands to 37.6
Base Case
$29.38
(+29%)
Market implied 28.4%, PE stable at 34.2
Bear Case
$15.57
(-32%)
Severe decline -20.0%, PE contracts to 29.0
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: May 15, 2026 6:26 AM ET
Data refreshes hourly during market hours. Next update: 7:26 AM
Data refreshes hourly during market hours. Next update: 7:26 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is HSTM showing a specific setup today?
Insider Activity (6 Months)
0
Buys
3
Sells
Net
INSIDERS SELLING
Recent Transactions
Jeff Cunningham
SELL
2100 shares
2025-12-10
Kevin P O'hara
SELL
2000 shares
2025-12-08
Tate Deborah Taylor
SELL
1580 shares
2025-11-26
Top Rated Health Information Services Stocks
Top-rated stocks in Health Information Services by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VEEV
Veeva Systems Inc Class A |
BUY
32 analysts |
$264 | 55 HOLD |
|
PRVA
Privia Health Group Inc |
STRONG BUY
21 analysts |
$32 | 57 HOLD |
|
GEHC
GE HealthCare Technologi… |
STRONG BUY
21 analysts |
$90 | 60 HOLD |
|
PHR
Phreesia Inc |
STRONG BUY
15 analysts |
$16 | 54 HOLD |
|
EVH
Evolent Health Inc |
STRONG BUY
14 analysts |
$5 | 60 HOLD |
